Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding ...

The launch marks the first medical cannabis products Aphria RX has grown under the medical cannabis cultivation license ...

Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after ...

Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...

Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth ...

Shares of Tilray Brands Inc. TLRY shed 2.04% to $1.44 Wednesday, on what proved to be an all-around mixed trading session for ...

Tilray Medical, a division of ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners ...

Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...

Blue Point Brewing Company, a subsidiary of Tilray Brands, announces Blitz Beer, a new American Lager added to Blue Point’s winter seasonal lineup. Available November through Fe ...

Wealth Enhancement Advisory Services LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent 13F ...

NEW YORK, NY Nov. 14, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a ...

Tilray Brands Inc. is trying to trick investors for a second straight year into increasing its share limit, according to a lawsuit against the Canadian cannabis company.